hs-CRP-Driven CCR2+ Monocyte Recruitment Disrupts CNS Immune Privilege via IL-1β Amplification
🧪 Overview
Circulating hs-CRP directly triggers CCR2+ monocyte recruitment to the CNS by enhancing CCL2 expression in brain endothelial cells and resident microglia through TLR4/MyD88 signaling. Once recruited, CCR2+ monocytes undergo rapid activation and begin secreting IL-1β, which creates a positive feedback loop by further stimulating microglial TLR4 receptors and promoting additional CCL2 release. This hs-CRP-initiated cascade fundamentally disrupts CNS immune privilege by establishing sustained peripheral immune cell infiltration rather than transient inflammatory responses. The hypothesis proposes that hs-CRP acts as the upstream molecular trigger that transforms the normally protective blood-brain barrier into a conduit for pathogenic monocyte invasion. Critical to this mechanism is that hs-CRP binding to microglial TLR4 receptors not only induces direct IL-1β secretion but simultaneously upregulates CCL2 production, creating a dual recruitment and activation signal.
...🧬 Mechanism
Curated pathway from expert analysis
flowchart TD
A["Circulating hs-CRP Elevation<br/>Systemic Inflammatory Signal"]
B["Microglial Fc/TLR4 Priming<br/>MyD88/NFkB Tone Increased"]
C["pro-IL1B Production<br/>Inflammasome Substrate Accumulates"]
D["NLRP3-Caspase-1 Cleavage<br/>Mature IL-1beta Release"]
E["Feed-Forward Neuroinflammation<br/>Synaptic Stress and Neuronal Injury"]
F["CRP Lowering or IL1B Blockade<br/>Inflammatory Amplifier Interrupted"]
A --> B
B --> C
C --> D
D --> E
F -.->|"blunts"| D
style A fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style E fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style F fill:#1b5e20,stroke:#81c784,color:#81c784⚖️ Evidence
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — CCR2
No curated PDB or AlphaFold mapping for CCR2 yet. Search RCSB →
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for CCR2.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
📊 Market Indicators
💾 Resource Usage
🔮 Predictions
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF human subjects with hs-CRP levels >3 mg/L receive a single dose of anti-hs-CRP monoclonal antibody (e.g., crp-b202 or analogous agent) THEN the absolute count of CCR2+ CD14+ monocytes in cerebrospi | ≥50% reduction in CSF CCR2+ CD14+ monocyte count from baseline in the treatment arm, with no significant change in the vehicle control arm | — no observation — | pending | 0.62 |
| IF primary human microglia cultures are pretreated with a TLR4 antagonist (e.g., TAK-242) or MyD88 adapter protein inhibitor for 30 minutes prior to hs-CRP exposure (10 μg/mL for 6h), THEN both CCL2 a | ≥70% reduction in CCL2 (pg/mL) and IL-1β (pg/mL) in supernatant from TAK-242-pretreated microglia exposed to hs-CRP versus vehicle-pretreated hs-CRP-exposed con | — no observation — | pending | 0.71 |
▸Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
| source | v1_phase_c_backfill |
| origin_type | gap_debate |
| _schema_version | 1 |